Varenicline Tartrate structure
|
Common Name | Varenicline Tartrate | ||
---|---|---|---|---|
CAS Number | 375815-87-5 | Molecular Weight | 361.35 | |
Density | N/A | Boiling Point | 400.6ºC at 760 mmHg | |
Molecular Formula | C17H19N3O6 | Melting Point | 206-208ºC | |
MSDS | Chinese USA | Flash Point | 48.2 °F | |
Symbol |
GHS02, GHS06, GHS08 |
Signal Word | Danger |
Use of Varenicline TartrateVarenicline Tartrate(CP 526555;Champix) is a nicotinic receptor partial agonist; it stimulates nicotine receptors more weakly than nicotine itself does.IC50 value:Target: α4β2 nAChRVarenicline(CP 526555; Champix; Chantix) is a prescription medication used to treat smoking addiction. As a partial agonist it both reduces cravings for and decreases the pleasurable effects of cigarettes and other tobacco products. Through these mechanisms Varenicline(CP 526555; Champix; Chantix) can assist some patients to quit smoking. |
Name | varenicline tartrate |
---|---|
Synonym | More Synonyms |
Description | Varenicline Tartrate(CP 526555;Champix) is a nicotinic receptor partial agonist; it stimulates nicotine receptors more weakly than nicotine itself does.IC50 value:Target: α4β2 nAChRVarenicline(CP 526555; Champix; Chantix) is a prescription medication used to treat smoking addiction. As a partial agonist it both reduces cravings for and decreases the pleasurable effects of cigarettes and other tobacco products. Through these mechanisms Varenicline(CP 526555; Champix; Chantix) can assist some patients to quit smoking. |
---|---|
Related Catalog | |
References |
[5]. Varenicline |
Boiling Point | 400.6ºC at 760 mmHg |
---|---|
Melting Point | 206-208ºC |
Molecular Formula | C17H19N3O6 |
Molecular Weight | 361.35 |
PSA | 23.79000 |
LogP | 4.49528 |
Storage condition | Desiccate at RT |
Water Solubility | DMSO: >5mg/mL |
Symbol |
GHS02, GHS06, GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H225-H301 + H311 + H331-H370 |
Precautionary Statements | P210-P260-P280-P301 + P310-P311 |
Hazard Codes | Xn,N,T,F |
Risk Phrases | 22-50-39/23/24/25-23/24/25-11 |
Safety Phrases | 22-57-45-36/37-16-7 |
RIDADR | UN 3077 9 / PGIII |
Flash Point(F) | 48.2 °F |
Flash Point(C) | 9 °C |
~64% Varenicline Tartrate CAS#:375815-87-5 |
Literature: Medichem, S.A. Patent: US2012/4239 A1, 2012 ; Location in patent: Page/Page column 12 ; |
Precursor 2 | |
---|---|
DownStream 0 |
Concurrent access to nicotine and sucrose in rats.
Psychopharmacol. Ser. 232(8) , 1451-60, (2015) Animal models that allow concurrent access to drug and nondrug reinforcers provide unique insight into the etiology, maintenance, and treatment of drug use.We sought to develop and utilize a concurren... |
|
Chronic treatment with varenicline changes expression of four nAChR binding sites in mice.
Neuropharmacology 99 , 142-55, (2015) Chronic treatment with nicotine is known to increase the α4β2-nAChR sites in brain, to decrease α6β2-nAChR sites and to have minimal effect on α3β4-and α7-nAChR populations. Varenicline is now used as... |
|
Effects of varenicline on ethanol-induced conditioned place preference, locomotor stimulation, and sensitization.
Alcohol. Clin. Exp. Res. 38(12) , 3033-42, (2015) Varenicline, a partial nicotinic acetylcholine receptor (nAChR) agonist, is a promising new drug for the treatment of alcohol (ethanol [EtOH]) dependence. Varenicline has been approved by the Food and... |
7,8,9,10-Tetrahydro-6,10-methano-6H-pyrazino[2,3-h][3]benzazepine tartrate Champix |
(2R,3R)-3-carboxy-2,3-dihydroxypropanoate de (1R,12S)-5,8-diaza-14-azoniatétracyclo[10.3.1.0.0]hexadéca-2(11),3,5,7,9-pentaène |
Chantix |
(1R,12S)-5,8-Diaza-14-azoniatetracyclo[10.3.1.0.0]hexadeca-2(11),3,5,7,9-pentaene (2R,3R)-3-carboxy-2,3-dihydroxypropanoate |
(1R,12S)-5,8-Diaza-14-azoniatetracyclo[10.3.1.0.0]hexadeca-2(11),3,5,7,9-pentaen-(2R,3R)-3-carboxy-2,3-dihydroxypropanoat |
Butanedioic acid, 2,3-dihydroxy-, (2R,3R)-, compd. with (6R,10S)-7,8,9,10-tetrahydro-6,10-methano-6H-azepino[4,5-g]quinoxaline (1:1) |
Champix |
Varenicline tartrate |